References
[1] Pountos, I., Corscadden, D., Emery, P., Giannoudis, P. V. (2007). Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application. Injury. 2007 Sep 1; 38: S23-33.
[2] Arthur, A., Zannettino, A., Gronthos, S. (2009). The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. Journal of Cellular Physiology. 2009 Feb; 218(2): 237-45.
[3] Song, L., Baksh, D., Tuan, R. S. (2004). Mesenchymal stem cell-based cartilage tissue engineering: cells, scaffold and biology. Cyto therapy. 2004 Dec 1; 6(6): 596-601.
[4] Vacanti, J. P., Langer, R. (1999). Tissue engineering: the design and fabrication of living replacement devices for surgical re-construction and transplantation. The lancet. 1999 Jul 1; 354: S32-4
[5] Audet, J. (2004). Stem cell bioengineering for regenerative medicine. Expert Opinion on Biological Therapy. 2004 May 1; 4(5): 631-44.
[6] Concise review: mesenchymal stem cell therapy for pediatric disease: perspectives on success and potential improvements. Stem Cells Translational Medicine. 2017 Feb; 6(2): 539-65.
[7] Lee, K. Y., Mooney, D. J. (2001). Hydrogels for tissue engineering. Chemical Reviews. 2001 Jul 11; 101(7): 1869-80.
[8] Steinert, A. F., Ghivizzani, S. C., Rethwilm, A., Tuan, R. S., Evans, C. H., Nöth, U. (2007). Major biological obstacles for per-sistent cell-based regeneration of articular cartilage. Arthritis Research & Therapy. 2007 Jun 1; 9(3): 213.
[9] Jana, S., Levengood, S. K., Zhang, M. (2016). Anisotropic materials for skeletal‐muscle‐tissue engineering. Advanced Materials. 2016 Dec; 28(48): 10588-612.
[10] Mauney, J. R., Volloch, V., Kaplan, D. L. (2005). Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Engineering. 2005 May 1; 11(5-6): 787-802.
[11] Saeedi, P., Halabian, R., Fooladi, A. A. (2019). A revealing review of mesenchymal stem cells therapy, clinical perspectives and modification strategies. Stem Cell Investigation. 2019; 6.
[12] McInnes, I. B., Schett, G. (2011). The pathogenesis of rheumatoid arthritis. New England Journal of Medicine. 2011 Dec 8; 365(23): 2205-19.
[13] Tsuchiya, A., Takeuchi, S., Iwasawa, T., Kumagai, M., Sato, T., Motegi, S., Ishii, Y., Koseki, Y., Tomiyoshi, K., Natsui, K., Takeda, N. (2020). Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases. Inflammation and Regeneration. 2020 Dec; 40(1): 1-6.
[14] Loy, H., Kuok, D. I., Hui, K. P., Choi, M. H., Yuen, W., Nicholls, J. M., Peiris, J. M., Chan, M. C. (2019). Therapeutic Impli-cations of Human Umbilical Cord Mesenchymal Stromal Cells in Attenuating Influenza A (H5N1) Virus–Associated Acute Lung Injury. The Journal of Infectious Diseases. 2019 Jan 7; 219(2): 186-96.
[15] Chen, J., Hu, C., Chen, L., Tang, L., Zhu, Y., Xu, X., Chen, L., Gao, H., Lu, X., Yu, L., Dai, X. (2020). Clinical study of me-senchymal stem cell treating acute respiratory distress syndrome induced by epidemic Influenza A (H7N9) infection, a hint for COVID-19 treatment. Engineering. 2020 Feb 28.
[16] Leng, Z., Zhu, R., Hou, W., Feng, Y., Yang, Y., Han, Q., Shan, G., Meng, F., Du, D., Wang, S., Fan, J. (2020). Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging and Disease. 2020 Apr; 11(2): 216.
[17] Wei, A., Shen, B., Williams, L., Diwan, A. (2014). Mesenchymal stem cells: potential application in intervertebral disc rege-neration. Translational Pediatrics. 2014 Apr; 3(2): 71.
[18] Lukomska, B., Stanaszek, L., Zuba-Surma, E., Legosz, P., Sarzynska, S., Drela, K. (2019). Challenges and controversies in human mesenchymal stem cell therapy. Stem Cells International. 2019 Apr 9.